Russia Puts The Squeeze On Essential Drug Prices
Pharmaceutical companies operating in Russia will need to re-register the prices of their medicines in 2019-20, according to a new law passed this month.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.